tapebrief
CTSH · Q1 2026

CTSH · Q2 2026 Earnings

Cautious

Cognizant

Reported July 29, 2026

30-second summary

Cognizant met its Q2 revenue guide at $5.48B (+4.5% YoY, +4.1% cc) but the FY2026 setup shifted materially: management cut the FY revenue growth ceiling by 150bps to 4.4–5.9% while raising the EPS growth range by 200–300bps to 8–10% — a margin-and-buyback-driven algorithm, not a top-line one. Q2 bookings declined 6% YoY, and the Q3 guide of 3.4–4.9% reported growth implies further deceleration. Financial Services printed a second consecutive double-digit quarter (+12%), but three of four segments grew ≤1.5% and the AI-builder story is now being tested against a bookings print that decisively broke the trend.

Headline numbers

EPS

Q2 FY2026

$1.37

-0.7% vs est.

Revenue

Q2 FY2026

$5.48B

+4.5% YoY

0.0% vs est.

Free cash flow

Q2 FY2026

$0.46B

Operating margin

Q2 FY2026

15.9%

Key financials

Q2 FY2026
MetricQ2 FY2026Q2 FY2025YoYQ1 FY2026QoQ
Revenue$5.48B$5.25B+4.5%$5.33B+2.8%
EPS$1.37$1.31+4.6%$1.35+1.5%
Operating margin15.9%15.6%+30bps16.0%-10bps
Free cash flow$0.46B$0.33B+38.7%$0.78B-41.2%

Guidance

Guidance is issued for both next quarter and the full year. Both may appear below.

Actuals vs prior guidance

MetricPeriodPrior guideActualΔResult
RevenueQ2 FY2026$5.36 to $5.44 billion$5.481 billionin-lineMet
Revenue YoY growthQ2 FY20264.8% to 6.3%4.5%in-lineMet
Revenue YoY growth (constant currency)Q2 FY20262.7% to 4.2%Not separately disclosedin-lineMet

New guidance

MetricPeriodGuideYoY
RevenueQ3 FY2026$5.60 to $5.68 billion+3.3% to +4.6%
Revenue YoY growthQ3 FY20263.4% to 4.9%3.4% to 4.9%
Revenue YoY growth (constant currency)Q3 FY20263.8% to 5.3%3.8% to 5.3%

Changes to prior guidance

MetricPeriodPrior guideNew guideΔResult
Adjusted Diluted EPS
FY2026
$5.56 to $5.70 (5% to 8% growth)$5.70 to $5.82 (8% to 10% growth)+$0.04 to +$0.12 at range endpoints; low end raised +$0.14, high end raised +$0.12; growth midpoint raised from 6.5% to 9%Raised
Adjusted Operating Margin
FY2026
15.9% to 16.1% (10 to 30 bps expansion)16.0% to 16.2% (20 to 40 bps expansion)+10 bps at low end, +10 bps at high end; expansion assumption raised from 10–30 bps to 20–40 bpsRaised
Revenue YoY growth
FY2026
4.9% to 7.4%4.4% to 5.9%-50 bps at low end, -150 bps at high end; range narrowed and shifted downLowered
Revenue YoY growth (constant currency)
FY2026
4.0% to 6.5%4.0% to 5.5%0 bps at low end, -100 bps at high endLowered
Adjusted Diluted EPS YoY growth
FY2026
5% to 8%8% to 10%+300 bps at low end, +200 bps at high endRaised

Segment performance

Q2 FY2026
SegmentQ2 FY2026Q2 FY2025YoY
Financial Services$1.733B$1.547B+12.0%
Health Sciences$1.572B$1.551B+1.4%
Products and Resources$1.322B$1.306B+1.2%
Communications, Media and Technology$0.854B$0.841B+1.5%

Platform metrics

Q2 FY2026
SegmentQ2 FY2026Q2 FY2025YoY
Trailing Twelve-Month Bookings$29.1 billion——
Book-to-Bill Ratio1.3x1.4x—
Q2 Bookings YoY Growth-6%——
Large Deals (>$100M TCV)7 deals in Q2——
Total Headcount356,700343,800—
Voluntary Attrition - Tech Services (TTM)13.0%——

Profitability

Q2 FY2026
SegmentQ2 FY2026Q2 FY2025YoY
Adjusted Operating Margin16.0%15.6%—
Adjusted Operating Margin YoY Expansion40 basis points——

Other KPIs

Q2 FY2026
SegmentQ2 FY2026Q2 FY2025YoY
North America$4.127B$3.912B+5.5%
Europe$1.027B$1.002B+2.5%
Rest of World$0.327B$0.331B-1.2%

Management tone

No transcript was available this quarter, so the tone read is limited to press-release language. Two shifts are visible in the disclosure itself. First, the qualitative statements pivot to more measured framing: "momentum continued…and was at the high end of our expectations." The bar has been lowered from beating raised guides to landing at the top of unrevised ones. Second, the FY26 revenue cut with EPS raise is itself a tonal signal — management is telling the market that the algorithm for 2026 will be delivered through margin and capital return, not top-line acceleration. The AI-builder narrative has not been abandoned ("market opportunity ahead is larger than ever"), but it is no longer being paired with an accelerating revenue print or an accelerating bookings print. Q2 bookings of -6% YoY is the single most consequential datapoint in the release, and the guidance revision reads as management pricing that in.

Answers to last quarter's watch list

Q2 FY26 cc growth landing inside the 2.7–4.2% range — Resolved positively on cc: Q2 cc growth of 4.1% landed at the top of the 2.7–4.2% guide. Reported growth of 4.5% came in 30bps below the low end of the 4.8–6.3% reported-growth guide but above the dollar-range high end. Status: Resolved (mixed — cc met at top, reported below low end on rate)
Whether FY26 cc range is tightened or raised mid-year — Cut, not raised. FY26 cc range moved from 4.0–6.5% to 4.0–5.5% — high end lowered 100bps, floor unchanged. Reported-basis range cut more aggressively: from 4.9–7.4% to 4.4–5.9%.
Resolved negatively
CMT stabilization — CMT grew +1.5% YoY reported (+1.4% cc) in Q2. Modestly positive but not clearly stabilizing at a growth rate that materially contributes to the mix.
Continue monitoring
Adjusted operating margin progression vs the 15.9–16.1% FY26 guide — Q2 adjusted operating margin printed 16.0% (+40bps YoY), and management raised the FY26 range to 16.0–16.2% with expansion widened to 20–40bps. Margin is the source of the EPS raise.
Resolved positively
Bookings momentum sustaining — Broken. Q2 bookings declined 6% YoY; TTM bookings of $29.1B grew 5% YoY at a 1.3x book-to-bill. Large-deal count (7 in Q2) is solid, but the aggregate bookings print is the first material crack and directly ties to the FY revenue guide cut.
Resolved negatively
3Cloud integration and M&A cadence — Astreya acquisition completed June 22, 2026 for $634 million (including $25 million contingent consideration, net of cash acquired), funded in part by $1.0B drawn under the revolving credit facility. Recently completed acquisitions contributed ~100bps to Q2 revenue growth.
Continue monitoring

What to watch into next quarter

Q3 bookings YoY growth turning positive vs. Q2's -6% print — The single most important datapoint. Bookings drive H2-26 and set up FY27. Two consecutive quarters of negative growth would decisively invalidate the "AI-builder demand acceleration" thesis.

Whether Q3 revenue prints in the upper half of $5.60–$5.68B — A low-end print (3.4% reported growth) would suggest the cut FY range still skews to its own lower half; an upper-half print keeps the 5.9% ceiling live.

Financial Services holding double-digit growth for a third consecutive quarter — At +12% and 32% of revenue, FS is now carrying the mix. If it decelerates below ~8% while other segments remain in the low single digits, FY revenue lands at or below the new 4.4% floor.

Health Sciences trajectory — At +1.4% reported (+1.0% cc), Health Sciences is now the weakest segment. Government funding pressure in healthcare warrants continued monitoring.

Whether FY26 EPS guide is raised again at Q3 — Management has raised the growth range from 5–8% to 8–10% while cutting revenue. If margin sustains at ≥16.0% through H2 and buyback pace holds (H1 repurchases of $1.6B already deployed), another EPS raise is plausible — this becomes the primary FY26 narrative.

Products & Resources ex-Belcan organic run rate — At +1.2% YoY reported (+0.7% cc) in Q2, watch whether P&R can hold positive growth or slides into contraction as tariff-affected discretionary continues to pressure the segment.

Attrition trajectory — Tech services voluntary attrition ticked up to 13.0% TTM from 12.3% at Q1-26. Further upward drift would pressure margin and challenge the operating-leverage story underpinning the EPS raise.

Sources

  1. Cognizant Q2 2026 press release (Exhibit 99.1, Form 8-K filed 2026-07-29) — https://www.sec.gov/Archives/edgar/data/1058290/000105829026000030/exhibit9916302026.htm

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.